Free Trial

Navidea Biopharmaceuticals (NAVB) Short Interest Ratio & Short Volume

Navidea Biopharmaceuticals logo
$0.0002 0.00 (0.00%)
As of 01:24 PM Eastern

Navidea Biopharmaceuticals Short Interest Data

Navidea Biopharmaceuticals (NAVB) has a short interest of 400 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 8,587 shares to cover all short positions.

Current Short Interest
400 shares
Previous Short Interest
400 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$0.28
Short Interest Ratio
0.4 Days to Cover
Last Record Date
May 31, 2025
Outstanding Shares
100,084,000 shares
Short Percent of Float
0.00%
Today's Trading Volume
159 shares
Average Trading Volume
8,587 shares
Today's Volume Vs. Average
2%
Short Selling Navidea Biopharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Navidea Biopharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

NAVB Short Interest Over Time

NAVB Days to Cover Over Time

NAVB Percentage of Float Shorted Over Time

Navidea Biopharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/2025400 shares $0.28 No Change0.0%0.4 $0.00
5/15/2025400 shares $0.28 +33.3%N/A0.4 $0.00
4/30/2025300 shares $0.18 -25.0%N/A0 $0.00
4/15/2025400 shares $0.24 No ChangeN/A0.1 $0.00
3/14/2025400 shares $0.04 No ChangeN/A0.2 $0.00
2/14/2025400 shares $0.28 No ChangeN/A0 $0.00
1/31/2025400 shares $0.40 No ChangeN/A0.1 $0.00
1/15/2025400 shares $0.04 No ChangeN/A0 $0.00
6/15/2023570,200 shares $51.32 thousand -35.3%4.5%0.1 $0.09
5/31/2023881,100 shares $81.06 thousand +1,888.9%3.7%0.4 $0.09
5/15/202344,300 shares $0.00 -92.5%0.2%0.1 $0.00
4/30/2023592,800 shares $0.00 +28.7%2.7%4.1 $0.00
4/15/2023460,700 shares $133.05 thousand -7.0%2.1%3.8 $0.29
3/31/2023495,500 shares $0.00 +6.3%2.3%3.7 $0.00
3/15/2023466,100 shares $0.00 +4.2%2.2%3.1 $0.00
2/28/2023447,300 shares $0.00 +2.0%2.1%3 $0.00
2/15/2023438,500 shares $0.00 +38.2%2.1%2.9 $0.00
1/31/2023317,300 shares $0.00 +660.9%1.5%2.3 $0.00
1/15/202341,700 shares $0.00 +118.3%0.2%0.4 $0.00
12/30/202219,100 shares $0.00 -83.7%0.1%0.2 $0.00
12/15/2022117,200 shares $0.00 -12.5%0.5%1.7 $0.00
11/30/2022133,900 shares $0.00 +27.5%0.6%1.3 $0.00
11/15/2022105,000 shares $0.00 -8.2%0.5%0.8 $0.00
10/31/2022114,400 shares $0.00 -50.2%0.5%0.7 $0.00
10/15/2022229,900 shares $0.00 -50.7%1.1%1.4 $0.00
9/30/2022466,700 shares $0.00 +20.2%2.2%3 $0.00
9/15/2022388,300 shares $0.00 +60.3%1.8%2.6 $0.00
8/31/2022242,300 shares $0.00 +319.9%1.1%2.3 $0.00
8/15/202257,700 shares $0.00 -2.9%0.3%0.9 $0.00
7/31/202259,400 shares $0.00 -38.1%0.3%1.4 $0.00
7/15/202296,000 shares $0.00 -5.0%0.4%1.9 $0.00
6/30/2022101,000 shares $0.00 +45.3%0.5%0.3 $0.00
6/15/202269,500 shares $0.00 -16.3%N/A0.2 $0.00
5/31/202283,000 shares $0.00 +2.1%0.4%0.2 $0.00
5/15/202281,300 shares $0.00 -63.6%0.4%0.2 $0.00
4/30/2022223,300 shares $0.00 +121.5%1.0%0.6 $0.00
4/15/2022100,800 shares $0.00 -1.0%0.5%0.3 $0.00
3/31/2022101,800 shares $0.00 -33.4%0.5%1.6 $0.00
3/15/2022152,800 shares $0.00 -15.9%0.7%2.1 $0.00
2/28/2022181,600 shares $0.00 -7.6%0.8%2.2 $0.00
When This Happens, You Don’t Wait. You Act. (Ad)

This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.

Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin
2/15/2022196,500 shares $0.00 -12.4%0.9%2.3 $0.00
1/31/2022224,400 shares $0.00 -1.4%1.0%2.4 $0.00
1/15/2022227,500 shares $0.00 +1.9%1.1%3.3 $0.00
12/31/2021223,200 shares $0.00 +63.9%1.0%3.1 $0.00
12/15/2021136,200 shares $0.00 -7.1%0.6%2.1 $0.00
11/30/2021146,600 shares $0.00 +4.1%0.7%2.3 $0.00
11/15/2021140,900 shares $0.00 -10.8%0.6%2.4 $0.00
10/29/2021157,900 shares $0.00 -9.3%0.7%2.9 $0.00
10/15/2021174,100 shares $0.00 -7.0%0.8%4 $0.00
9/30/2021187,200 shares $0.00 +13.8%0.9%3 $0.00
9/15/2021164,500 shares $0.00 -5.4%0.8%2.5 $0.00
8/31/2021173,800 shares $0.00 +9.3%0.8%2.4 $0.00
8/13/2021159,000 shares $0.00 -17.0%0.7%1.4 $0.00
7/30/2021191,500 shares $0.00 -4.3%0.9%1.5 $0.00
7/15/2021200,000 shares $0.00 -1.6%1.0%1.4 $0.00
6/30/2021203,200 shares $0.00 +12.3%1.0%1.4 $0.00
6/15/2021181,000 shares $0.00 +30.2%0.9%0.9 $0.00
5/28/2021139,000 shares $0.00 -23.4%0.7%0.7 $0.00
5/14/2021181,500 shares $0.00 +5.5%N/A0.8 $0.00
4/30/2021172,000 shares $0.00 -7.2%N/A0.6 $0.00
4/15/2021185,300 shares $290.92 thousand -15.5%N/A0.5 $1.57
3/31/2021219,400 shares $355.43 thousand +49.3%N/A0.6 $1.62
3/15/2021147,000 shares $255.78 thousand -22.3%N/A0.4 $1.74
2/26/2021189,200 shares $389.75 thousand +13.8%N/A0.6 $2.06
2/12/2021166,200 shares $402.20 thousand -33.0%N/A0.5 $2.42
1/29/2021248,100 shares $615.29 thousand -8.4%N/A0.6 $2.48
1/15/2021270,800 shares $785.32 thousand -2.9%N/A0.9 $2.90
12/31/2020279,000 shares $558 thousand -1.6%N/A1.1 $2.00
12/15/2020283,500 shares $532.98 thousand +9.0%N/A1.2 $1.88
11/30/2020260,000 shares $624 thousand +32.9%N/A1.1 $2.40
11/15/2020195,600 shares $539.86 thousand +3.4%N/A0.8 $2.76
10/30/2020189,100 shares $457.62 thousand -3.3%N/A1.1 $2.42
10/15/2020195,600 shares $535.94 thousand -11.1%N/A0.8 $2.74
9/30/2020220,100 shares $594.27 thousand +11.4%N/A0.7 $2.70
9/15/2020197,500 shares $582.63 thousand -12.7%1.1%0.6 $2.95
8/31/2020226,100 shares $671.52 thousand +5.0%1.3%0.5 $2.97
8/14/2020215,300 shares $704.03 thousand -5.2%1.3%0.3 $3.27
7/31/2020227,000 shares $1.09 million -37.0%1.3%0.1 $4.78
7/15/2020360,500 shares $1.44 million -15.6%2.1%0.2 $3.99
6/30/2020427,100 shares $1.63 million -20.5%2.7%0.2 $3.81

NAVB Short Interest - Frequently Asked Questions

What is Navidea Biopharmaceuticals' current short interest?

Short interest is the volume of Navidea Biopharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 400 shares of NAVB short. 0.00% of Navidea Biopharmaceuticals' shares are currently sold short. Learn More on Navidea Biopharmaceuticals' current short interest.

What is a good short interest percentage for Navidea Biopharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Navidea Biopharmaceuticals' floating shares are currently sold short.

How does Navidea Biopharmaceuticals' short interest compare to its competitors?

0.00% of Navidea Biopharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Navidea Biopharmaceuticals: TC Biopharm (Holdings) Plc (176.43%), Vincerx Pharma, Inc. (0.05%), Smart for Life, Inc. (0.01%), Ampio Pharmaceuticals, Inc. (0.01%), Evelo Biosciences, Inc. (0.04%), Comera Life Sciences Holdings, Inc. (0.02%), Genocea Biosciences, Inc. (0.33%), Aridis Pharmaceuticals, Inc. (0.00%), Statera Biopharma, Inc. (0.15%), Clever Leaves Holdings Inc. (0.52%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

What does it mean to sell short Navidea Biopharmaceuticals stock?

Short selling NAVB is an investing strategy that aims to generate trading profit from Navidea Biopharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Navidea Biopharmaceuticals?

A short squeeze for Navidea Biopharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NAVB, which in turn drives the price of the stock up even further.

How often is Navidea Biopharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NAVB, twice per month. The most recent reporting period available is May, 31 2025.




This page (NYSE:NAVB) was last updated on 6/25/2025 by MarketBeat.com Staff
From Our Partners